|
List Info
Thread: 3776 2 Died of Viral Brain Infection After Taking Rituxan to Treat Lupus, FDA Says (Why is this not
|
|
| 3776 2 Died of Viral Brain Infection
After Taking Rituxan to Treat Lupus, FDA
Says (Why is this not |

|
2006-12-28 01:27:56 |
|
| FDA Warns of Deaths Linked to Rituxan
2 Died of Viral Brain Infection After Taking Rituxan to Treat Lupus,
FDA Says
By Miranda Hitti WebMD Medical News
Reviewed By Louise Chang, MD on Tuesday, December 19,
2006
Dec. 19, 2006 -- The FDA has issued a public health advisory on
Rituxan after two lupus patients taking the drug reportedly died of a viral
brain infection.
Both patients developed progressive multifocal leukoencephalopathy (PML), a
brain infection caused by a common but usually harmless virus. However, in those
who contract PML, the infection is usually fatal; there are no effective
treatments.
Rituxan is a powerful drug used to suppress the immune system. It works by
blocking the effect of specific immune cells in the blood, known as B cells, for
up to nine months.
The drug is approved for use only in patients with certain types of cancer,
called non-Hodgkin’s lymphoma, and for rheumatoid arthritis when other
treatments have failed. Rituxan is not approved to treat lupus.
However, Rituxan's maker, Genentech, estimates that approximately 10,000
lupus patients have been treated with Rituxan, according to the FDA.
The FDA is working to gather more information about Rituxan and PML, and to
strengthen the drug's warnings about PML.
Signs of PML Patients treated with Rituxan should contact
their doctor if they experience any warning sign of PML, says the FDA.
Signs of the disease include confusion, dizziness or loss of balance,
difficulty talking or walking, and vision problems.
These symptoms are also associated with the underlying diseases for which
Rituxan may be prescribed, making it harder to spot PML, the FDA notes.
The FDA advises doctors considering treating a patient with Rituxan to inform
that patient about the chance of developing PML.
Patients taking or considering taking Rituxan should be aware of the chance
of developing PML and ought to discuss it with their doctor, the FDA adds.
Rituxan's labeling was updated in February 2006 to include information about
reports of several different types of viral infections, including PML, that had
become active again or worsened in cancer patients taking the drug.
Source: www.medicinenet.com
| Comment: Rituxan is a powerful immune suppressing
drug approved only to treat few types of cancers and only when other
treatments have failed. With such a limited approval, and especially when
it is not even approved to treat Lupus, its maker, Genetech estimates that
over 10,000 Lupus patients are taking this dangerous drug. The drug label
was updated in Feb 2006 for the cancer patients as well, so why is the
drug still being used for this off label use? Its manufacturers are making
millions of dollars while people are suffering from deadly infections.
This once again highlights how the drug companies are more focused on the
business than the health of patients. Dr. Rath has been emphasizing this
very fact for more than a decade now. You can read more about the
pharmaceutical Business with Disease in the News section on www.drrathresearch.org. |
--~--~---------~--~----~------------~-------~--~----~
You received this message because you are subscribed to the Google Groups "MedicalConspiracies" group.
To post to this group, send email to:
MedicalConspiracies googlegroups.com
To unsubscribe from this group, send email to:
MedicalConspiracies-unsubscribe googlegroups.com
For more options, visit this group at:
http://groups.google.com/group/MedicalConspiracies
«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤«¤»¥«¤»§«¤»¥«¤»§«
If Paranormal Research and Medical Conspiracies are of interest check out:
Paranormal_Research = Scientific Data & Health Conspiracies
To visit Paranormal_Research on the web, go to:
http://groups.yahoo.com/group/Paranormal_Research/
To subscribe to this group, send an email to:
Paranormal_Research-subscribe@yahoogroups.com
Any information here in is for educational purpose only, it may be news related, purely speculation or someone's opinion, If health related always consult with a qualified health practitioner before deciding on any course of treatment, especially for serious or life-threatening illnesses.
**COPYRIGHT NOTICE**
In accordance with Title 17 U.S.C. Section 107,
any copyrighted work in this message is distributed under fair use without profit or payment to those who have expressed a prior interest in receiving the included information for non-profit research and educational purposes only. http://www.law.cornell.edu/uscode/17/107.shtml -~----------~----~----~----~------~----~------~--~---
|
[1]
|
|
|
about | contact Other archives ( Real Estate discussion Medical topics )
|